Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures
Open Access
- 1 December 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
- Vol. 2 (6), e161
- https://doi.org/10.1212/nxi.0000000000000161
Abstract
Objective: To characterize the clinical features and MRI abnormalities of leucine-rich glioma-inactivated 1 (LGI1)-autoantibody (Ab) faciobrachial dystonic seizures (FBDS). Methods: Forty-eight patients with LGI1-Ab encephalopathy were retrospectively identified by searching our clinical and serologic database from January 1, 2002, to June 1, 2015. Of these, 26 met inclusion criteria for this case series: LGI1-Ab seropositivity and FBDS. In a separate analysis of all 48 patients initially identified, the MRIs of patients with (n = 26) and without (n = 22) FBDS were compared by 2 neuroradiologists blinded to the clinical details. Results: The median age of the 26 included patients was 62.5 years (range 37–78); 65% were men. FBDS involved arm (26), face (22), and leg (12). Ten were previously diagnosed as psychogenic. Ictal EEGs were normal in 20 of 23 assessed. Basal ganglia T1 and T2 signal abnormalities were detected in 11 patients (42%), with excellent agreement between neuroradiologists (κ scores of 0.86 and 0.93, respectively), and included T1 hyperintensity alone (2), T2 hyperintensity alone (1), or both (8). The T1 hyperintensities persisted longer than the T2 hyperintensities (median 11 weeks vs 1 week, p = 0.02). Improvement with immunotherapy (18/18) was more frequent than with antiepileptic medications (10/24). A separate analysis of all 48 patients initially identified with LGI1-Ab encephalopathy showed that basal ganglia MRI abnormalities were present in 11 of 26 with FBDS but not present in those without FBDS (0/22) (p < 0.001). In contrast, mesial temporal MRI abnormalities were less common among those with FBDS (42%) than those without (91%) (p < 0.001). Conclusions: Basal ganglia T1 hyperintensity is a clinically useful MRI biomarker of LGI1-Ab FBDS and suggests a basal ganglia localization.Keywords
This publication has 25 references indexed in Scilit:
- Clinical Reasoning: A 72-year-old man with rapid cognitive decline and unilateral muscle jerksNeurology, 2014
- Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsyNeurology, 2014
- Limbic Encephalitis Associated With Anti–Voltage-Gated Potassium Channel Complex Antibodies Mimicking Creutzfeldt-Jakob DiseaseJAMA Neurology, 2014
- Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotypeBrain, 2013
- Faciobrachial dystonic seizures arise from cortico–subcortical abnormal brain areasZeitschrift für Neurologie, 2013
- Insights From LGI1 and CASPR2 Potassium Channel Complex Autoantibody SubtypingJAMA Neurology, 2013
- Intracranial Lesions with High Signal Intensity on T1-weighted MR Images: Differential DiagnosisRadioGraphics, 2012
- Faciobrachial dystonic attacks: Seizures or movement disorder?Annals of Neurology, 2011
- Clinical spectrum of voltage-gated potassium channel autoimmunityNeurology, 2008
- A Short Test of Mental Status: Description and Preliminary ResultsMayo Clinic Proceedings, 1987